Rapid progress in synthetic biology and genetic engineering drives demand for DNA synthesis to design novel biological systems. Research and Development (R&D) Investments: Increasing investments in ...
Mandell's tenure, MaxCyte has achieved significant milestones including its initial public offering on the UK AIM exchange and US Nasdaq Listing, the launch of its flagship ExPERT™ platform, signing ...
Stifel Financial Corp cut its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 20.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 40,237 ...
BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...